Estimation of the number of women living with metastatic breast cancer in the United States

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 6, 2017, Pages 809-815

  Mariotto, Angela B ^a   Etzioni, Ruth ^b   Hurlbert, Marc ^c,d   Penberthy, Lynne ^a   Mayer, Musa ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b USA   (United States)

^c Metastatic Breast Cancer Network   (United States)

^d Breast Cancer Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CALCULATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; MEDIAN SURVIVAL TIME; METASTATIC BREAST CANCER; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES; BREAST TUMOR; METASTASIS; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; UNITED STATES; YOUNG ADULT;

EID: 85020191575     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0889     Document Type: Article

References (19)

1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66:271-89.
2. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011;103:117-28.
3. Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, et al. Impact of symptom burden onwork-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. Breast 2014;23:763-9.
4. Yang HC, Thornton LM, Shapiro CL, Andersen BL. Surviving recurrence: psychological and quality-of-life recovery. Cancer 2008;112:1178-87.
5. Mayer M.Lessons learned from the metastatic breast cancer community. Semin Oncol Nurs 2010;26:195-202.
6. Aranda S, Schofield P, Weih L, Yates P, Milne D, Faulkner R, et al. Mapping the quality of life and unmet needs of urban women with metastatic breast cancer. Eur J Cancer Care 2005;14:211-22.
7. Byrne J, Kessler LG,Devesa SS. The prevalence of cancer among adults in the United States: 1987. Cancer 1992;69:2154-9.
8. De Angelis G, De Angelis R, Frova L, Verdecchia A. MIAMOD: A computer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed 1994;44:99-107.
9. Verdecchia A, Capocaccia R, Egidi V, Golini A. A method for the estimation of chronic disease morbidity and trends from mortality data. Stat Med 1989;8:201-16.
10. Clements MS, Roder DM, Yu XQ, Egger S, O'Connell DL. Estimating prevalence of distant metastatic breast cancer: A means of filling a data gap. Cancer Cause Control 2012;23:1625-34.
11. De Angelis R, Tavilla A, Verdecchia A, Scoppa S, Hachey M, Feuer EJ, et al. Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015. Cancer 2009;115:1954-66.
12. Surveillance Epidemiology and End Results Program (SEER) Adjusted AJCC 6th Edition Stage Classification [website]. Available from:https://seer.cancer.gov/seerstat/variables/seer/ajcc-stage/6th/#stage.
13. Yu B, Tiwari RC, Cronin KA, Feuer EJ. Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med 2004; 23:1733-47.
14. Yu B, Tiwari RC, Cronin KA, McDonald C, Feuer EJ. CANSURV: A Windows program for population-based cancer survival analysis. Comput Methods Programs Biomed 2005;80:195-203.
15. Dawood S, Broglio K, Ensor J, Hortobagyi GN, Giordano SH. Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol 2010;21:2169-74.
16. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000. Cancer 2004;100:44-52.
17. Chia SK, Speers CH, D'yachkova Y, Kang A, Malfair-Taylor S, Barnett J, et al. The impact of new chemotherapeutic and agents on survival in a population-based of women with metastatic breast cancer hormone cohort. Cancer 2007;110:973-9.
18. Pal SK, Dehaven M, Nelson RA, Onami S, Hsu J, Waliany S, et al. Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer. BMC Cancer 2012;12.
19. Johnson RH, Chien FL, Bleyer A. Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009. JAMA 2013;309:800-5.